tiprankstipranks
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL

Autolus Therapeutics (AUTL) Financial Statements

497 Followers

Autolus Therapeutics Financial Overview

Autolus Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.198; its P/E ratio is -5.15; Autolus Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-$ 2.37M$ 0.00$ 0.00$ 823.00K
Gross Profit-----
EBIT-$ -47.07M$ -47.72M$ -40.90M$ -47.60M
EBITDA-$ -45.28M$ -45.80M$ -38.83M$ -45.50M
Net Income Common Stockholders-$ -42.77M$ -42.06M$ -37.06M$ -41.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 382.76M$ 163.05M$ 216.44M$ 268.56M$ 310.34M
Total Assets$ 490.27M$ 263.83M$ 313.98M$ 363.99M$ 405.56M
Total Debt$ 24.26M$ 15.13M$ 17.20M$ 19.25M$ 21.00M
Net Debt$ -358.50M$ -147.93M$ -199.23M$ -249.30M$ -289.34M
Total Liabilities$ 191.60M$ 102.68M$ 99.45M$ 92.85M$ 92.24M
Stockholders Equity$ 298.67M$ 161.15M$ 214.52M$ 271.14M$ 313.32M
Cash Flow-
Free Cash Flow-$ -38.70M$ -33.45M$ -35.80M$ -10.74M
Operating Cash Flow-$ -31.90M$ -30.81M$ -35.03M$ -9.16M
Investing Cash Flow-$ -6.80M$ -2.64M$ -771.00K$ -1.58M
Financing Cash Flow-$ 102.00K$ 0.00$ -1.00K$ 147.41M
Currency in USD

Autolus Therapeutics Earnings and Revenue History

Autolus Therapeutics Debt to Assets

Autolus Therapeutics Cash Flow

Autolus Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis